From discussions of late-stage investigational therapies to emerging evidence that may shape future clinical practice, the SLEEP 2026 conference in Baltimore highlighted the remarkable pace of innovation across sleep medicine.
As someone who spends much of my time thinking about how new evidence becomes meaningful education, I found myself asking a different question: How do we help clinicians translate these advances into better care for the patients and families sitting across from them?
The role of patients, caregivers, and family members
Throughout the meeting, discussions around narcolepsy, idiopathic hypersomnia, sleep apnea, and other chronic sleep disorders consistently emphasized the important role of patients, caregivers, and family members in recognizing symptoms, navigating what is often a lengthy diagnostic journey, supporting treatment decisions, and managing these conditions over the long term.
Those perspectives are more than compelling stories. They provide context that can strengthen continuing medical education and ultimately support better patient care.
Clinical trials provide evidence about the safety and efficacy of therapies under carefully studied conditions. Patient and caregiver experiences help us understand what happens when that evidence reaches clinical practice:
- The barriers to diagnosis
- The realities of living with chronic disease
- The challenges of treatment adherence
- The outcomes that matter most to patients and families
The future of CME
That's why I believe the future of CME isn't simply about delivering the latest science. It's about helping HCPs translate emerging evidence into meaningful, patient-centered care by integrating the lived experiences of patients and caregivers alongside the clinical data.
Scientific innovation changes what's possible, but patient and caregiver perspectives help us understand what is practical. High-quality CME should bring both together.
